Shaping the future with momentum
At Guardion, we seek out opportunities that inspire us and drive momentum for our company as we shape the future through the power of intention and innovation. At the forefront of these opportunities is our investment in science-based, clinically supported products that serve humanity’s desire to stay dynamic and active.
Advancing health with velocity
Advancing health with velocity
The Guardion team is working to get nutritionally beneficial, easy-to-use products into the market with greater velocity to help mitigate nutrient gaps that can negatively impact metabolic processes in the body. Knowing that our customers want to get results as quickly as possible, we act with that same sense of urgency to create effective, evidence-based products so that customers don’t face the forces of aging alone.
over
million
Over 11 million people in the US have some form of Age-related Macular Degeneration (AMD).
more than
million
More than 2 million fractures occur in adults 50+ each year at a cost of more than $17 billion.
Impacting markets with energy
Impacting markets with energy
At Guardion, we focus our energy on large, important segments that meet fundamental needs for an active lifestyle. From medical foods for age-related macular degeneration to dietary supplements for osteoporosis and bone health, our products serve growing populations while meeting new opportunities with innovation.
Growing value with stability
Guardion’s well-architected business and marketing strategies are setting a course for stable growth and a steadfast commitment to our people-first mission. Our recent acquisition of Viactiv®, for example, provides a significant boost to our current revenues and operating earnings while driving exploration of opportunities in the wider world of clinical nutrition.
Growing value with stability
Guardion’s well-architected business and marketing strategies are setting a course for stable growth and a steadfast commitment to our people-first mission. Our recent acquisition of Viactiv®, for example, provides a significant boost to our current revenues and operating earnings while driving exploration of opportunities in the wider world of clinical nutrition.
